Jeffrey H. Meyer

13.9k citations

153 papers · 9.9k indexed · 2 hit papers · h-index 50

Impact in

Biological Psychiatry top 0.05%
- Tryptophan and brain disorders
Behavioral Neuroscience top 0.2%
- Stress Responses and Cortisol

Papers in

Biological Psychiatry 40
- Tryptophan and brain disorders 40
Cellular and Molecular Neuroscience 71
- Neurotransmitter Receptor Influence on Behavior 54
- Neuroscience and Neuropharmacology Research 22

Co-authors: Sylvain Houle Alan A. Wilson Nathalie Ginovart Pablo Rusjan Doug Hussey Sidney H. Kennedy Romina Mizrahi Sandra Sagrati
Journals: Biological Psychiatry (13 papers)American Journal of Psychiatry (11 papers)Neuropsychopharmacology (11 papers)Journal of Cerebral Blood Flow & Metabolism (7 papers)Psychopharmacology (6 papers)
Partner nations: Canada United States Japan

In The Last Decade

Jeffrey H. Meyer

148 papers receiving 9.7k citations

Hit Papers

align trajectories log scale

Role of Translocator Protein Density, a Marker of Neuroinflammation, in the Brain During Major Depressive Episodes 2015 · 685 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2015 JAMA Psychiatry
2001 American Journal of Psychiatry

Peers

Countries citing papers authored by Jeffrey H. Meyer

Since Specialization

Citations

This map shows the geographic impact of Jeffrey H. Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey H. Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey H. Meyer more than expected).

Fields of papers citing papers by Jeffrey H. Meyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey H. Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey H. Meyer. The network helps show where Jeffrey H. Meyer may publish in the future.

Co-authors

The 25 scholars most cited alongside Jeffrey H. Meyer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jeffrey H. Meyer Line = papers co-authored together Jeffrey H. Meyer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Fatty acid amide hydrolase in major depressive episodes: A [11C]CURB positron emission tomography study Neuropsychopharmacology ·Dorsa Rafiei, Michelle De Pol, Jeffrey H. Meyer, Kimberly L. Desmond, Ruth A. Ross, Isabelle Boileau, Jerry J. Warsh, Pablo Rusjan, Neil Vasdev, Ryan Aloysius, Lauren Gray, Nathan J. Kolla	2025	1
2	Dietary supplement for mood symptoms in early postpartum: a double-blind randomized placebo controlled trial EClinicalMedicine ·Jeffrey H. Meyer, Zhaohui Wang, Apitharani Santhirakumar, Yekta Dowlati, Natalia Docteur, Aqsa Shoaib, Jareeat Purnava, Yanqi Wang, Wei Wang, Sheng Chen, Muhammad Ishrat Husain, Rashmi de Silva Wijeyeratne, Heba Reeyaz, Catalina Baena-Tan, Yuko Koshimori, Zahra Nasser, Valery Sit	2024	1
3	Cigarette smoking is associated with reduced neuroinflammation and better cognitive control in people living with HIV Neuropsychopharmacology ·Arthur L. Brody, Anna K. Mischel, Andre Y. Sanavi, Alvin Wong, Ji Hye Bahn, Arpi Minassian, Erin E. Morgan, Brinda K. Rana, Carl K. Hoh, David R. Vera, Kishore K. Kotta, Alannah Miranda, Nina Pocuca, Thomas J. Walter, Natalie Guggino, Renee Beverly-Aylwin, Jeffrey H. Meyer, Neil Vasdev, Jared W. Young	2024	2
4	Evidence of altered monoamine oxidase B, an astroglia marker, in early psychosis and high-risk state Molecular Psychiatry ·Kankana Nisha Aji, Nittha Lalang, Christian Ramos-Jiménez, Reza Rahimian, Naguib Mechawar, Gustavo Turecki, Daniel Chartrand, Isabelle Boileau, Jeffrey H. Meyer, Pablo Rusjan, Romina Mizrahi	2024	3
5	Astrogliosis marker 11C-SL25.1188 PET in traumatic brain injury with persistent symptoms Brain ·Yuko Koshimori, Michael D. Cusimano, Érica Leandro Marciano Vieira, Pablo Rusjan, Stephen J. Kish, Neil Vasdev, Sho Moriguchi, Isabelle Boileau, Thomas Chao, Zahra Nasser, Muhammad Ishrat Husain, Khunsa Faiz, Joeffre Braga, Jeffrey H. Meyer	2023	5
6	First-in-Human PET Imaging of [¹⁸F]SDM-4MP3: A Cautionary Tale Molecular Imaging ·Kimberly L. Desmond, Anton Lindberg, Armando García, Junchao Tong, Michael B. Harkness, Elena Dobrota, Kelly Smart, Carme Uribe, Jeffrey H. Meyer, Sylvain Houle, Antonio P. Strafella, Songye Li, Yiyun Huang, Neil Vasdev	2023	3
7	Potential therapeutic benefits of cannabinoid products in adult psychiatric disorders: A systematic review and meta-analysis of randomised controlled trials Journal of Psychiatric Research ·Kyle McKee, Amira Hmidan, Candice E. Crocker, Raymond W. Lam, Jeffrey H. Meyer, David Crockford, Annie Trépanier, Katherine J. Aitchison, Philip G. Tibbo	2021	23
8	Imaging of astrocytes in posttraumatic stress disorder: A PET study with the monoamine oxidase B radioligand [11C]SL25.1188 European Neuropsychopharmacology ·Talwinder Gill, Sarah E. Watling, J. Don Richardson, Tina McCluskey, Junchao Tong, Jeffrey H. Meyer, Jerry J. Warsh, Rakesh Jetly, Michael G. Hutchison, Shawn G. Rhind, Sylvain Houle, Neil Vasdev, Stephen J. Kish, Isabelle Boileau	2021	22
9	Recent developments on PET radiotracers for TSPO and their applications in neuroimaging Acta Pharmaceutica Sinica B ·Lingling Zhang, Kuan Hu, Tuo Shao, Lu Hou, Shaojuan Zhang, Weijian Ye, Lee Josephson, Jeffrey H. Meyer, Ming‐Rong Zhang, Neil Vasdev, Jinghao Wang, Hao Xu, Lu Wang, Steven H. Liang	2020	116
10	Minocycline as adjunctive treatment for treatment-resistant depression: study protocol for a double blind, placebo-controlled, randomized trial (MINDEP2) BMC Psychiatry ·Muhammad Ishrat Husain, Clare Cullen, Madeha Umer, André F. Carvalho, Stefan Kloiber, Jeffrey H. Meyer, Abigail Ortiz, Yuliya Knyahnytska, (unknown), Justine L. Giddens, Breno S. Diniz, Wei Wang, Allan H. Young, Benoit H. Mulsant, Zafiris J. Daskalakis	2020	21
11	Differential levels of prefrontal cortex glutamate+glutamine in adults with antisocial personality disorder and bipolar disorder: A proton magnetic resonance spectroscopy study Progress in Neuro-Psychopharmacology and Biological Psychiatry ·Areti Smaragdi, Sofia Chavez, Nancy J. Lobaugh, Jeffrey H. Meyer, Nathan J. Kolla	2019	19
12	Association of translocator protein total distribution volume with duration of untreated major depressive disorder: a cross-sectional study The Lancet Psychiatry ·Elaine Setiawan, Sophia Attwells, Alan A. Wilson, Romina Mizrahi, Pablo Rusjan, Laura Miler, Cynthia Xu, Sarita Sharma, Stephen J. Kish, Sylvain Houle, Jeffrey H. Meyer	2018	163
13	Elevated Monoamine Oxidase-A Distribution Volume in Borderline Personality Disorder Is Associated With Severity Across Mood Symptoms, Suicidality, and Cognition Biological Psychiatry ·Nathan J. Kolla, Lina Chiuccariello, Alan A. Wilson, Sylvain Houle, Paul S. Links, R. Michael Bagby, Shelley McMain, Charis Kellow, Jalpa Patel, P. Vivien Rekkas, Suvercha Pasricha, Jeffrey H. Meyer	2014	32
14	Mechanistic Role for a Novel Glucocorticoid-KLF11 (TIEG2) Protein Pathway in Stress-induced Monoamine Oxidase A Expression Journal of Biological Chemistry ·Matthew Grunewald, Shakevia Johnson, Deyin Lu, Zhe Wang, Gwen Lomberk, Paul R. Albert, Craig A. Stockmeier, Jeffrey H. Meyer, Raúl Urrutia, Klaus A. Miczek, Mark C. Austin, Junming Wang, Ian A. Paul, William L. Woolverton, Seungmae Seo, Donald B. Sittman, Xiao-Ming Ou	2012	84
15	Neuroimaging Markers of Cellular Function in Major Depressive Disorder: Implications for Therapeutics, Personalized Medicine, and Prevention Clinical Pharmacology & Therapeutics ·Jeffrey H. Meyer	2012	49
16	The Reduction of R1, a Novel Repressor Protein for Monoamine Oxidase A, in Major Depressive Disorder Neuropsychopharmacology ·Shakevia Johnson, Craig A. Stockmeier, Jeffrey H. Meyer, Mark C. Austin, Paul R. Albert, Junming Wang, Warren L. May, Grażyna Rajkowska, James C. Overholser, George Jurjus, Lesa Dieter, Chandra Johnson, Donald B. Sittman, Xiao‐Ming Ou	2011	67
17	Serotonin transporter occupancy of high-dose selective serotonin reuptake inhibitors during major depressive disorder measured with [11C]DASB positron emission tomography Psychopharmacology ·Aristotle N. Voineskos, Alan A. Wilson, Anahita Boovariwala, Sandra Sagrati, Sylvain Houle, Pablo Rusjan, Stephen T.H. Sokolov, Edgar P. Spencer, Nathalie Ginovart, Jeffrey H. Meyer	2007	46
18	Brain serotonin transporter binding in non‐depressed patients with Parkinson's disease European Journal of Neurology ·Mark Guttman, Isabelle Boileau, Jerry J. Warsh, Jean A. Saint‐Cyr, Nathalie Ginovart, Tina McCluskey, Sylvain Houle, Alan A. Wilson, Emanuela Mundo, Pablo Rusjan, Jeffrey H. Meyer, Stephen J. Kish	2007	146
19	Structure–activity relationships and sub-type selectivity in an oxabicyclic estrogen receptor α/β agonist scaffold Bioorganic & Medicinal Chemistry Letters ·Lawrence G. Hamann, Jeffrey H. Meyer, Daniel A. Ruppar, Keith B. Marschke, Francisco J. López, Elizabeth A. Allegretto, Donald S. Karanewsky	2005	36
20	Occupancy of Serotonin Transporters by Paroxetine and Citalopram During Treatment of Depression: A [¹¹C]DASB PET Imaging Study American Journal of Psychiatry ·Jeffrey H. Meyer, Alan A. Wilson, Nathalie Ginovart, Verdell S. Goulding, Doug Hussey, Karen M. Hood, Sylvain Houle	2001	270

About Jeffrey H. Meyer

Jeffrey H. Meyer is a scholar working on Biological Psychiatry, Cellular and Molecular Neuroscience, Behavioral Neuroscience, Pharmacology and Neurology, having authored 153 papers that have together received 9.9k indexed citations. Recurring topics across this work include Neurotransmitter Receptor Influence on Behavior (54 papers), Treatment of Major Depression (42 papers), Tryptophan and brain disorders (40 papers), Neuroscience and Neuropharmacology Research (22 papers), Functional Brain Connectivity Studies (22 papers), Medical Imaging Techniques and Applications (15 papers), Neuroinflammation and Neurodegeneration Mechanisms (14 papers) and Stress Responses and Cortisol (11 papers). The work is most often cited by research in Biological Psychiatry (2.4k citations), Behavioral Neuroscience (1.4k citations), Cellular and Molecular Neuroscience (3.5k citations), Neurology (1.3k citations) and Pharmacology (2.1k citations). Jeffrey H. Meyer has collaborated with scholars based in Canada, United States and Japan. Frequent co-authors include Sylvain Houle, Alan A. Wilson, Nathalie Ginovart, Pablo Rusjan, Doug Hussey, Sidney H. Kennedy, Romina Mizrahi, Sandra Sagrati, Laura Miler and Stephen J. Kish. Their work appears in journals such as Biological Psychiatry, American Journal of Psychiatry, Neuropsychopharmacology, Journal of Cerebral Blood Flow & Metabolism and Psychopharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact